Skip to content

Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery

Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery: A Randomized, Controlled, Double-Blinded Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05191745
Enrollment
60
Registered
2022-01-13
Start date
2022-01-26
Completion date
2024-06-01
Last updated
2024-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft Surgery

Keywords

Cardiac surgery, Pain

Brief summary

This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary artery bypass grafting surgery.

Detailed description

This study will randomize patients to either standard pain control protocols or parasternal blocks after coronary artery bypass grafting-only surgery. This study will specifically examine the effectiveness and duration of analgesia of parasternal blocks with local anesthetic adjuncts, Dexamethasone 10mg and Dexmedetomidine 50mcg, added to the local anesthetic mixture

Interventions

Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg

DRUGStandard of care

All standard management of postoperative pain, as per local protocols

Sponsors

Jewish General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients coming for elective and urgent coronary artery bypass (CABG)-only surgery.

Exclusion criteria

* Patients with a history of regular opioid use. * Patients with a history of chronic pain. * Patients unable to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Pain with inspirometry at 24 hours after surgery24 hours after surgeryNumerical Rating Scale (NRS) pain score from the sternotomy site during inspirometry. The VAS score is a scale from 0 to 10 where 0 is equivalent to no pain and 10 is equal to the worst imaginable pain

Secondary

MeasureTime frameDescription
Amount of rescue analgesia administeredTotal in the first 48 hours after surgeryAmount of ketorolac or ketamine administered
Opioid consumption12, 24 and 48 hours after surgeryAmount of opioid administered (mg of Dilaudid)
Pain score at rest12, 24 and 48 hours after surgeryNumerical Rating Scale (NRS) pain score from the sternotomy site during inspirometry. The VAS score is a scale from 0 to 10 where 0 is equivalent to no pain and 10 is equal to the worst imaginable pain
Pain score with inspirometry12 and 48 hours after surgeryNumerical Rating Scale (NRS) pain score from the sternotomy site during inspirometry. The VAS score is a scale from 0 to 10 where 0 is equivalent to no pain and 10 is equal to the worst imaginable pain
Intensive Care Unit (ICU) Length of StayFrom surgery until discharge from the ICU, assessed from the date of surgery up until 6 months after the completion of the studyTime spent in the intensive care unit after surgery (days)
Hospital Length of StayFrom the date of surgery up until discharge from hospital, followed from the date of surgery up until 6 months after the completion of the studyTime spent in the hospital after surgery (days)
Inspirometry24 hours after surgeryVolume inspired on inspirometry
Patient satisfaction with pain controlat 48 hours after surgery0 extremely unsatisfied to 10 extremely satisfied
MobilizationFrom ICU arrival until first mobilization (approximately first 48 hours postoperatively)Time from ICU arrival to the first mobilization to a chair
AmbulationFrom ICU arrival until first ambulation (approximately first 72 hours postoperatively)Time from ICU arrival to the first mobilization to a chair

Other

MeasureTime frameDescription
Incidence of hyperglycemiafirst 48 hours after surgeryGlucose greater than 10 millimoles/liter
Incidence of a pneumothoraxfirst 48 hours after surgeryPneumothorax identified on chest x-ray
Local anesthetic toxicityfirst 48 hours after surgeryLocal anesthetic toxicity, as diagnosed clinically
Postoperative Deliriumfirst 48 hours after surgeryDelirium as defined by the Confusion assessment method for the ICU (CAM-ICU)
Narcotic prescription on dischargeUpon discharge from hospital after surgery (approximately 1 week after surgery)Having a narcotic prescription on discharge
Sternal pain at 3 monthsThree months after the day of surgeryPersistent pain at the sternum
Local anesthetic spreadImmediately as intervention is performedNumber of levels of spread of local anesthetic, as identified by ultrasound
Incidence of bradycardiafirst 48 hours after surgeryHeart rate less than 60 beats per minute
Presence of postoperative vomitingfirst 48 hours after surgeryVomiting after surgery

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026